SYK and Hepatic fibrosis: Studies have shown that the use of SYK kinase inhibitors to block SYK phosphorylation can effectively reduce the development of various liver diseases, including liver fibrosis, alcoholic liver disease, non-alcoholic fatty liver, hepatocellular carcinoma [5, 7].